Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07055152

Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
University of Pisa · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate microvascular dysfunction through OCTA in MINOCA patients. In order to better understand the condition, OCTA will also be performed in two matched patient groups: healthy controls and ACS patients. The study will compare the retinal microvascular parameters across these groups to determine differences in microvascular function in MINOCA patients. Additionally, in the MINOCA subgroup, the study will further evaluate the differences in microvascular dysfunction within specific subsets of patients (e.g., Takotsubo, vasospastic angina, microvascular angina, patients with evidence of plaque erosion) to understand the variability and potential mechanisms underlying each subgroup of MINOCA.

Conditions

Timeline

Start date
2025-01-01
Primary completion
2026-01-01
Completion
2027-01-01
First posted
2025-07-08
Last updated
2025-07-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07055152. Inclusion in this directory is not an endorsement.

Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients (NCT07055152) · Clinical Trials Directory